Kindred Biosciences, Inc.
Erythropoietin Analogs For Veterinary Use

Last updated:

Abstract:

Provided are various embodiments relating to erythropoietin (EPO) polypeptide analogs with one or more additional glycosylation sites and/or additional cysteine residues and methods of producing and using the same to treat anemia in companion animals. Also provided are various embodiments relating to polypeptides comprising an extracellular domain of EPO receptor and methods of using the same for treating polycythemia in mammals.

Status:
Application
Type:

Utility

Filling date:

12 Dec 2019

Issue date:

27 Jan 2022